Provider
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Program effective Date: Jul 12, 2023
Documents & Forms Results
Displaying 1091 - 1100 of 4307 results
Financial Information
Provider
commercial-gc-019-professional-and-technical-components-for-applicable-services.pdf
Financial Information
Provider
commercial-si-002-bilateral-procedures.pdf
Financial Information
Provider
commercial-si-004-modifier-22.pdf
Provider
P88-23 New Commercial Reimbursement Policy: New Patient, Effective February 5, 2024
Program effective Date: Dec 01, 2023
Provider
P89-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Program effective Date: Dec 01, 2023
Provider
P90-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Program effective Date: Dec 01, 2023
Provider
P91-23 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective February 5, 2024
Program effective Date: Dec 01, 2023
Provider
P92-23 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Dec 01, 2023
Provider
P93-23 Additional Information for Minnesota Health Care Programs (MHCP) Operations Transitioning back to Blue Cross, effective January 1, 2024
Program effective Date: Dec 01, 2023